![](/img/cover-not-exists.png)
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Watts, Gerald F., Chan, Dick C., Pang, Jing, Ma, Louis, Ying, Qidi, Aggarwal, Shashi, Marcovina, Santica M., Barrett, P. Hugh R.Volume:
107
Journal:
Metabolism
DOI:
10.1016/j.metabol.2020.154221
Date:
June, 2020
File:
PDF, 715 KB
2020